home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Pharmaceutical Dissolution Testing

 
  July 14, 2014  
     
 
PharmCourses Ltd, london
6 & 7 October 2014


Dissolution and drug release tests are directly relevant to the safety and efficacy of many

common pharmaceutical dosage forms. To achieve reliable and reproducible results, it is important that analysts understand the importance of correctly setting up and sampling from the chosen apparatus.  In addition to use of dissolution testers, this two-day course will also cover equipment qualification, development and validation of dissolution procedures, and the use of dissolution testing in the assessment of bioavailability and bioequivalence.

Who should attend?

This course is aimed at those new to dissolution testing and analysts with previous experience seeking to improve their skills and knowledge.

Day 1

Why do we perform dissolution testing?

Dissolution theory, sink conditions and intrinsic dissolution rate

Dissolution and drug release testing apparatus

· Rotating basket (USP Apparatus 1)

· Rotating paddle (USP Apparatus 2)

· Reciprocating cylinder (USP Apparatus 3)

· Flow-through cell (USP Apparatus 4)

· Paddle over disc (USP Apparatus 5)

· Rotating cylinder (USP Apparatus 6)

· Reciprocating holder (USP Apparatus 7)

· Franz cell

Requirements for different dosage form types (including data interpretation)

· Immediate release

· Extended release

· Delayed release

· Transdermal delivery systems

 

Day 2

Dissolution equipment qualification

Dissolution method development

· General requirements

· Selection of dissolution medium

· Apparatus and agitation

· Sampling (time points & filtration)

· Assay requirements

 

Dissolution method validation

· Setting acceptance criteria with reference to drug product specifications

· Specificity

· Linearity/range

· Accuracy/recovery

· Precision

· Robustness

· Solution stability

Dissolution and the assessment of bioavailability/bioequivalence

  

 
 
Organized by: PharmaTraining Ltd
Invited Speakers: Dr Mark Powell
 
Deadline for Abstracts: .
 
Registration: Online registration available
E-mail: judy@pharma-training-courses.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.